Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 8
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer.
Voskuilen CS, van Gennep EJ, Einerhand SMH, Vegt E, Donswijk ML, Bruining A, van der Poel HG, Horenblas S, Hendricksen K, van Rhijn BWG, Mertens LS. Voskuilen CS, et al. Among authors: einerhand smh. Eur Urol Oncol. 2022 Jun;5(3):366-369. doi: 10.1016/j.euo.2021.01.005. Epub 2021 Feb 11. Eur Urol Oncol. 2022. PMID: 33583752
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
Einerhand SMH, van Dijk N, van Dorp J, de Feijter JM, van Montfoort ML, van de Kamp MW, Schaake EE, Boellaard TN, Hendricksen K, van der Heijden MS, van Rhijn BWG. Einerhand SMH, et al. Int J Cancer. 2022 Dec 1;151(11):2004-2011. doi: 10.1002/ijc.34125. Epub 2022 Jun 10. Int J Cancer. 2022. PMID: 35603905 Clinical Trial.
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
Lonati C, Afferi L, Mari A, Minervini A, Krajewski W, Borghesi M, Schulz GB, Rink M, Montorsi F, Briganti A, Colombo R, Martini A, Necchi A, Contieri R, Hurle R, Umari P, Zamboni S, Simeone C, Soria F, Marra G, Gontero P, Teoh JY, Klatte T, Bajeot AS, Roumiguié M, Rouprêt M, Masson-Lecomte A, Laukhtina E, Valiquette AS, Mir MC, Antonelli A, Einerhand SMH, Hendricksen K, Carando R, Fankhauser CD, Baumeister P, Mattei A, Shariat SF, Moschini M; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Lonati C, et al. Among authors: einerhand smh. World J Urol. 2022 May;40(5):1167-1174. doi: 10.1007/s00345-022-03958-9. Epub 2022 Feb 26. World J Urol. 2022. PMID: 35218372
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
Einerhand SMH, Black AJ, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, van Rhijn BWG, Black PC, Mertens LS. Einerhand SMH, et al. World J Urol. 2022 Nov;40(11):2707-2715. doi: 10.1007/s00345-022-04160-7. Epub 2022 Sep 28. World J Urol. 2022. PMID: 36169695 Free PMC article.
Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.
Hinsenveld FJ, Boormans JL, van der Poel HG, van der Schoot DKE, Vis AN, Aben KKH, Arends TJ, Ausems PJ, Baselmans D, Berger C, Berrens A, Bickerstaffe H, Bos SD, Braam M, Buddingh KT, Claus S, Dekker K, van Doeveren T, Einerhand S, Fossion L, van Gennep EJ, van Ginkel N, Palacios G, Hermans T, Hobijn MM, van Huystee SH, Jaspers-Valentijn M, Klaver OS, Koldewijn EL, Korsten L, Lenting A, Lentjes KJ, Luiting HB, van der Meer S, Nieuwenhuijzen JA, Noordzij MA, Nooter RI, Notenboom C, Oomen R, van Roermund J, de Rooij J, Roshani H, Schrier BP, van der Slot MA, Somford DM, Stelwagen PJ, Stroux A, van der West A, Wijsman BP, Windt W, van Zanten P, van Beek SC; Dutch Cystectomy Snapshot Group. Hinsenveld FJ, et al. Among authors: einerhand s. Urol Oncol. 2022 Feb;40(2):60.e1-60.e9. doi: 10.1016/j.urolonc.2021.06.018. Epub 2021 Jul 22. Urol Oncol. 2022. PMID: 34303597 Free article.
13 results